{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:27:42Z","timestamp":1786980462952,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"President Foundation of The Fifth Affiliated Hospital, Southern Medical University","award":["No. YZ2020MS04"],"award-info":[{"award-number":["No. YZ2020MS04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurogenetics"],"DOI":"10.1007\/s10048-024-00792-6","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T01:02:26Z","timestamp":1733446946000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mendelian randomization study of causal link from Cerebrospinal fluid metabolomics to neurodegenerative diseases"],"prefix":"10.1007","volume":"26","author":[{"given":"Jingjing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiecai","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"key":"792_CR1","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1242\/dmm.030205","volume":"10","author":"AD Gitler","year":"2017","unstructured":"Gitler AD, Dhillon P, Shorter J (2017) Neurodegenerative disease: models, mechanisms, and a new hope. Dis Models Mech 10:499\u2013502","journal-title":"Dis Models Mech"},{"key":"792_CR2","doi-asserted-by":"crossref","unstructured":"Botas A, Campbell HM, Han X, Maletic-Savatic M Metabolomics of neurodegenerative diseases. in Int Rev Neurobiol 122 53\u201380 (Elsevier, 2015).","DOI":"10.1016\/bs.irn.2015.05.006"},{"key":"792_CR3","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"E Nichols","year":"2022","unstructured":"Nichols E et al (2022) Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of Disease Study 2019. Lancet Public Health 7:e105\u2013e125","journal-title":"Lancet Public Health"},{"key":"792_CR4","doi-asserted-by":"publisher","first-page":"101580","DOI":"10.1016\/j.eclinm.2022.101580","volume":"51","author":"A Nandi","year":"2022","unstructured":"Nandi A et al (2022) Global and regional projections of the economic burden of Alzheimer\u2019s disease and related dementias from 2019 to 2050: a value of statistical life approach. eClinicalMedicine 51:101580","journal-title":"eClinicalMedicine"},{"key":"792_CR5","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3233\/JPD-212936","volume":"12","author":"C Liguori","year":"2022","unstructured":"Liguori C et al (2022) Biomarkers of cerebral glucose metabolism and neurodegeneration in Parkinson\u2019s Disease: a cerebrospinal fluid-based study. JPD 12:537\u2013544","journal-title":"JPD"},{"key":"792_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neulet.2015.03.051","volume":"594","author":"A \u00d6hman","year":"2015","unstructured":"\u00d6hman A, Forsgren L (2015) NMR metabonomics of cerebrospinal fluid distinguishes between Parkinson\u2019s disease and controls. Neurosci Lett 594:36\u201339","journal-title":"Neurosci Lett"},{"key":"792_CR7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12974-016-0502-1","volume":"13","author":"M Albanese","year":"2016","unstructured":"Albanese M et al (2016) Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression. J Neuroinflammation 13:36","journal-title":"J Neuroinflammation"},{"key":"792_CR8","doi-asserted-by":"crossref","unstructured":"Arlt S et al (2012) Homocysteine Metabolism, and cerebrospinal fluid markers for Alzheimer\u2019s Disease. JAD 31:751\u2013758Dimethylarginines","DOI":"10.3233\/JAD-2012-112138"},{"key":"792_CR9","doi-asserted-by":"publisher","first-page":"105785","DOI":"10.1016\/j.jsbmb.2020.105785","volume":"205","author":"T Jahn","year":"2021","unstructured":"Jahn T et al (2021) Cholesterol metabolites and plant sterols in cerebrospinal fluid are associated with Alzheimer\u2019s cerebral pathology and clinical disease progression. J Steroid Biochem Mol Biol 205:105785","journal-title":"J Steroid Biochem Mol Biol"},{"key":"792_CR10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1194\/jlr.P071639","volume":"58","author":"J Abdel-Khalik","year":"2017","unstructured":"Abdel-Khalik J et al (2017) Defective cholesterol metabolism in amyotrophic lateral sclerosis. J Lipid Res 58:267\u2013278","journal-title":"J Lipid Res"},{"key":"792_CR11","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3109\/21678421.2015.1053490","volume":"16","author":"E Gray","year":"2015","unstructured":"Gray E et al (2015) The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degeneration 16:456\u2013463","journal-title":"Amyotroph Lateral Scler Frontotemporal Degeneration"},{"key":"792_CR12","doi-asserted-by":"crossref","unstructured":"Emdin CA, Khera AV, Kathiresan S (2017) Mendelian Randomization JAMA 318:1925","DOI":"10.1001\/jama.2017.17219"},{"key":"792_CR13","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/sim.3034","volume":"27","author":"DA Lawlor","year":"2008","unstructured":"Lawlor DA, Harbord RM, Sterne JAC, Timpson N (2008) Davey Smith, G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 27:1133\u20131163","journal-title":"Stat Med"},{"key":"792_CR14","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"G Davey Smith","year":"2014","unstructured":"Davey Smith G, Hemani G (2014) Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet 23:R89\u2013R98","journal-title":"Hum Mol Genet"},{"key":"792_CR15","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1371\/journal.pmed.0050177","volume":"5","author":"NA Sheehan","year":"2008","unstructured":"Sheehan NA, Didelez V, Burton PR, Tobin MD (2008) Mendelian randomisation and causal inference in Observational Epidemiology. PLoS Med 5:e177","journal-title":"PLoS Med"},{"key":"792_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s42003-020-01583-z","volume":"4","author":"DJ Panyard","year":"2021","unstructured":"Panyard DJ et al (2021) Cerebrospinal fluid metabolomics identifies 19 brain-related phenotype associations. Commun Biol 4:63","journal-title":"Commun Biol"},{"key":"792_CR17","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez C et al (2022) New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet 54:412\u2013436","journal-title":"Nat Genet"},{"key":"792_CR18","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1038\/s41588-021-00954-4","volume":"53","author":"L Jiang","year":"2021","unstructured":"Jiang L, Zheng Z, Fang H, Yang J (2021) A generalized linear mixed model association tool for biobank-scale data. Nat Genet 53:1616\u20131621","journal-title":"Nat Genet"},{"key":"792_CR19","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41588-021-00973-1","volume":"53","author":"W Van Rheenen","year":"2021","unstructured":"Van Rheenen W et al (2021) Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. Nat Genet 53:1636\u20131648","journal-title":"Nat Genet"},{"key":"792_CR20","unstructured":"International Multiple Sclerosis Genetics Consortium (2019) Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science 365"},{"key":"792_CR21","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41588-020-00776-w","volume":"53","author":"J Schwartzentruber","year":"2021","unstructured":"Schwartzentruber J et al (2021) Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer\u2019s disease risk genes. Nat Genet 53:392\u2013402","journal-title":"Nat Genet"},{"key":"792_CR22","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","volume":"53","author":"S Sakaue","year":"2021","unstructured":"Sakaue S et al (2021) A cross-population atlas of genetic associations for 220 human phenotypes. Nat Genet 53:1415\u20131424","journal-title":"Nat Genet"},{"key":"792_CR23","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls MA et al (2019) Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol 18:1091\u20131102","journal-title":"Lancet Neurol"},{"key":"792_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bpsgos.2021.03.002","volume":"1","author":"KP Glanville","year":"2021","unstructured":"Glanville KP, Coleman JRI, O\u2019Reilly PF, Galloway J, Lewis CM (2021) Investigating Pleiotropy between Depression and Autoimmune diseases using the UK Biobank. Biol Psychiatry Glob Open Sci 1:48\u201358","journal-title":"Biol Psychiatry Glob Open Sci"},{"key":"792_CR25","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/ije\/dyq151","volume":"40","author":"BL Pierce","year":"2011","unstructured":"Pierce BL, Ahsan H, VanderWeele TJ (2011) Power and instrument strength requirements for mendelian randomization studies using multiple genetic variants. Int J Epidemiol 40:740\u2013752","journal-title":"Int J Epidemiol"},{"key":"792_CR26","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen C-Y, Neale B, Do R (2018) Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases. Nat Genet 50:693\u2013698","journal-title":"Nat Genet"},{"key":"792_CR27","doi-asserted-by":"publisher","first-page":"e34408","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani G et al (2018) The MR-Base platform supports systematic causal inference across the human phenome. eLife 7:e34408","journal-title":"eLife"},{"key":"792_CR28","doi-asserted-by":"publisher","first-page":"R1198","DOI":"10.1016\/j.cub.2017.09.017","volume":"27","author":"A Orts-Del\u2019Immagine","year":"2017","unstructured":"Orts-Del\u2019Immagine A, Wyart C (2017) Cerebrospinal-fluid-contacting neurons. Curr Biol 27:R1198\u2013R1200","journal-title":"Curr Biol"},{"key":"792_CR29","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3390\/metabo12040343","volume":"12","author":"K Wakamatsu","year":"2022","unstructured":"Wakamatsu K et al (2022) Metabolites and biomarker compounds of neurodegenerative diseases in Cerebrospinal Fluid. Metabolites 12:343","journal-title":"Metabolites"},{"key":"792_CR30","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.bbi.2023.04.015","volume":"111","author":"L Bakker","year":"2023","unstructured":"Bakker L et al (2023) Correlations between kynurenines in plasma and CSF, and their relation to markers of Alzheimer\u2019s disease pathology. Brain Behav Immun 111:312\u2013319","journal-title":"Brain Behav Immun"},{"key":"792_CR31","doi-asserted-by":"publisher","first-page":"1214932","DOI":"10.3389\/fnagi.2023.1214932","volume":"15","author":"R Dong","year":"2023","unstructured":"Dong R et al (2023) CSF metabolites associated with biomarkers of Alzheimer\u2019s disease pathology. Front Aging Neurosci 15:1214932","journal-title":"Front Aging Neurosci"},{"key":"792_CR32","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3233\/JAD-170485","volume":"60","author":"LM Giil","year":"2017","unstructured":"Giil LM et al (2017) Kynurenine Pathway metabolites in Alzheimer\u2019s Disease. JAD 60:495\u2013504","journal-title":"JAD"},{"key":"792_CR33","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3390\/ph16040615","volume":"16","author":"A Heylen","year":"2023","unstructured":"Heylen A et al (2023) Brain kynurenine pathway metabolite levels may reflect extent of Neuroinflammation in ALS, FTD and early onset AD. Pharmaceuticals 16:615","journal-title":"Pharmaceuticals"},{"key":"792_CR34","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.cmet.2023.06.004","volume":"35","author":"C Xue","year":"2023","unstructured":"Xue C et al (2023) Tryptophan metabolism in health and disease. Cell Metabol 35:1304\u20131326","journal-title":"Cell Metabol"},{"key":"792_CR35","doi-asserted-by":"publisher","DOI":"10.47626\/1516-4446-2022-2962","author":"BS Fernandes","year":"2023","unstructured":"Fernandes BS, Inam ME, Enduru N, Quevedo J, Zhao Z (2023) The kynurenine pathway in Alzheimer\u2019s disease: a meta-analysis of central and peripheral levels. Brazilian J Psychiatry. https:\/\/doi.org\/10.47626\/1516-4446-2022-2962","journal-title":"Brazilian J Psychiatry"},{"key":"792_CR36","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.semcdb.2015.03.002","volume":"40","author":"DC Maddison","year":"2015","unstructured":"Maddison DC, Giorgini F (2015) The kynurenine pathway and neurodegenerative disease. Semin Cell Dev Biol 40:134\u2013141","journal-title":"Semin Cell Dev Biol"},{"key":"792_CR37","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1016\/j.neurobiolaging.2013.02.021","volume":"34","author":"L Chouliaras","year":"2013","unstructured":"Chouliaras L et al (2013) Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer\u2019s disease patients. Neurobiol Aging 34:2091\u20132099","journal-title":"Neurobiol Aging"},{"key":"792_CR38","doi-asserted-by":"publisher","first-page":"e185","DOI":"10.1212\/NXI.0000000000000185","volume":"3","author":"E Cocco","year":"2016","unstructured":"Cocco E et al (2016) 1 H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 3:e185","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"792_CR39","doi-asserted-by":"publisher","first-page":"578105","DOI":"10.1016\/j.jneuroim.2023.578105","volume":"379","author":"A Ge","year":"2023","unstructured":"Ge A, Sun Y, Kiker T, Zhou Y, Ye K (2023) A metabolome-wide mendelian randomization study prioritizes potential causal circulating metabolites for multiple sclerosis. J Neuroimmunol 379:578105","journal-title":"J Neuroimmunol"},{"key":"792_CR40","doi-asserted-by":"publisher","first-page":"109225","DOI":"10.1016\/j.isci.2024.109225","volume":"27","author":"AE Oppong","year":"2024","unstructured":"Oppong AE et al (2024) Blood metabolomic and transcriptomic signatures stratify patient subgroups in multiple sclerosis according to disease severity. iScience 27:109225","journal-title":"iScience"},{"key":"792_CR41","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1074\/jbc.M115.676510","volume":"291","author":"X Zou","year":"2016","unstructured":"Zou X et al (2016) Acetoacetate accelerates muscle regeneration and ameliorates muscular dystrophy in mice. J Biol Chem 291:2181\u20132195","journal-title":"J Biol Chem"},{"key":"792_CR42","doi-asserted-by":"publisher","first-page":"5344","DOI":"10.1007\/s00415-023-11844-6","volume":"270","author":"S Sassi","year":"2023","unstructured":"Sassi S et al (2023) Retrospective observational study on the use of acetyl-l-carnitine in ALS. J Neurol 270:5344\u20135357","journal-title":"J Neurol"},{"key":"792_CR43","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.3390\/antiox12101887","volume":"12","author":"E Grossini","year":"2023","unstructured":"Grossini E et al (2023) Effects of Acetyl-L-Carnitine on oxidative stress in amyotrophic lateral sclerosis patients: evaluation on plasma markers and members of the neurovascular unit. Antioxidants 12:1887","journal-title":"Antioxidants"},{"key":"792_CR44","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3109\/17482968.2010.491867","volume":"11","author":"DJ Amante","year":"2010","unstructured":"Amante DJ et al (2010) Uridine ameliorates the pathological phenotype in transgenic G93A-ALS mice. Amyotroph Lateral Scler 11:520\u2013530","journal-title":"Amyotroph Lateral Scler"},{"key":"792_CR45","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1039\/C5MB00711A","volume":"12","author":"A Wuolikainen","year":"2016","unstructured":"Wuolikainen A et al (2016) Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson\u2019s disease and control subjects. Mol BioSyst 12:1287\u20131298","journal-title":"Mol BioSyst"},{"key":"792_CR46","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.3233\/JAD-200671","volume":"80","author":"S Kim","year":"2021","unstructured":"Kim S, Kim K, Nho K, Myung W, Won H-H (2021) Shared genetic background between cerebrospinal fluid biomarkers and risk for Alzheimer\u2019s Disease: a two-sample mendelian randomization study. JAD 80:1197\u20131207","journal-title":"JAD"},{"key":"792_CR47","doi-asserted-by":"publisher","first-page":"e16359","DOI":"10.15252\/emmm.202216359","volume":"15","author":"O Hansson","year":"2023","unstructured":"Hansson O et al (2023) The genetic regulation of protein expression in cerebrospinal fluid. EMBO Mol Med 15:e16359","journal-title":"EMBO Mol Med"},{"key":"792_CR48","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1111\/jnc.15937","volume":"166","author":"J Cheng","year":"2023","unstructured":"Cheng J, Deng Y, Yu J (2023) The causal role of circulating amino acids on neurodegenerative disorders: a two-sample mendelian randomization study. J Neurochem 166:972\u2013981","journal-title":"J Neurochem"}],"container-title":["Neurogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-024-00792-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10048-024-00792-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-024-00792-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T05:01:58Z","timestamp":1769403718000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10048-024-00792-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["792"],"URL":"https:\/\/doi.org\/10.1007\/s10048-024-00792-6","relation":{},"ISSN":["1364-6753"],"issn-type":[{"value":"1364-6753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,6]]},"assertion":[{"value":"31 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing financial interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"15"}}